IDPAT Psychedelic Research Conference 2024

The first psychedelic research conference in Ireland, hosted by Irish Doctors for Psychedelic Assisted Therapy and Trinity College Dublin Psychedelic Research Group. The sold out event took place in the Edmund Burke Theatre, Trinity College Dublin on Friday October 25th 2024.

Speakers:

DR DAVID ERRITZOE
David Erritzoe is Clinical Director of Imperial College London’s Centre for Psychedelic Research. He is a consultant psychiatrist at St Charles Hospital where he leads a ground-breaking research initiative that aims to unlock new therapies for mental health and neuroscience. His focus is on experimental psychopharmacology, specifically investigating the effects of classic psychedelics and ketamine in healthy and psychiatric populations. By using cutting-edge imaging methods such as PET, MRI, and EEG, David hopes to uncover the compounds' therapeutic potential and mechanisms, including brain plasticity and psychological flexibility.


PROF. PETER HENDRICKS
Peter Hendricks is Professor at University of Alabama, Birmingham, USA. Peter is currently researching the use of psilocybin to see if it will help individuals addicted to cocaine stop using the harmful drug. He theorizes that psilocybin, which is the active compound found in Psilocybe mushrooms, also known as “magic mushrooms,” will work from various angles: biochemical, psychological and transcendental/spiritual. Peter will talk about his research as well as novel and more effective treatments for substance abuse dependence, with specific areas of focus on tobacco, cocaine and polysubstance abuse in vulnerable populations.


DR ROBERTA MURPHY
Dr Roberta Murphy is an Irish psychiatrist based in London. She is currently training as a medical psychotherapist in South West London and St George’s NHS Trust. She is a member of the Imperial Centre for Psychedelic Research. She worked as a study doctor and therapy guide on trials of psilocybin for healthy volunteers, severe depression and eating disorders. She has helped to train other research teams and offers support around issues pertaining to screening. Her research focuses on the importance of the psychotherapeutic relationship to achieve the best clinical outcomes in psychedelic therapy.


DR DAVID LUKE
Dr David Luke is an Associate Professor of Psychology at the University of Greenwich. He is currently a module leader of the Psychology of Exceptional Human Experience. Dr Luke is also an Honorary Senior Lecturer at the Centre for Psychedelic Research, Imperial College London. He is a lecturer on the MSc Consciousness, Spirituality and Transpersonal Psychology where he leads and teaches a module on Psychedelics and Entheogens. David's particular interest is in transpersonal experiences, anomalous phenomena and altered states of consciousness. He has published over 100 academic papers and 10 books in this field.


TIMMY DAVIS
Timmy Davis is the Policy Director at the Psilocybin Access Rights (#PAR) campaign and manages the Psilocybin Rescheduling Project at the Centre for Evidence-Based Drug Policy. He is a contributing member of Drug Science's Medical Psychedelics Working Group and a guide on the psilocybin for treatment resistant depression trials at Kings College London, as well as a welfare and harm reduction manager at music festivals in the UK and abroad. He holds an MA in Psychoanalytic Studies and a BA Hons in Philosophy and Religion from the university of Kent, where he was president of the UKC Psychedelic Society for three years.


DR GUILLAUME THUERY
Guillaume Thuery is a postdoctoral researcher at Trinity College Dublin, where he investigates the immuno-modulatory and antidepressant effects of psychedelics. He holds a PhD in Neurogenetics from TCD. Guillaume uses a variety of techniques, such as microscopy, molecular biology, and behavioral assays, to understand the mechanisms and effects of these compounds on the brain and the immune system.